Form 4: Bimergen CFO Reprices Options Up, Receives New Grant

Bimergen Energy Corp's CFO and Director, Robert J. Brilon, received a new grant of 210,000 stock options and had 71,429 existing options repriced to a higher exercise price of $4.50 per share.

Summary

• Robert J. Brilon, Chief Financial Officer and Director of Bimergen Energy Corp (BESS), reported changes in his beneficial ownership of derivative securities.
• On August 26, 2025, Mr. Brilon was granted 210,000 new stock options with an exercise price of $4.50 per share, expiring on August 26, 2035.
• These new options vest in three equal annual installments, with the first third becoming exercisable on August 26, 2025, the second third on the first annual anniversary, and the final third on the second annual anniversary of the transaction date.
• Also on August 26, 2025, 71,429 of Mr. Brilon's previously held options were repriced to an exercise price of $4.50 per share.
• These repriced options originally had varying exercise prices ranging from $0.50 to $1.50 per share and maintain their original vesting schedule and expiration date of May 3, 2034.
• A disposition of 71,429 options on May 3, 2024, is noted, which is part of the repricing transaction where the original options were effectively exchanged for new ones at the higher exercise price.

Sentiment

Score: 7

Explanation: The grant of new options incentivizes the CFO, and the repricing of existing options to a higher exercise price ($4.50 from $0.50-$1.50) demonstrates a commitment to higher performance targets for a portion of his equity compensation, which is a positive for shareholders. While there is potential dilution from the new grant, the overall alignment of incentives is favorable.

Positives

• The grant of 210,000 new stock options to the CFO aligns his interests with shareholder value creation, incentivizing him to drive company performance.
• The repricing of 71,429 existing options to a significantly higher exercise price of $4.50 per share (from original prices ranging $0.50-$1.50) demonstrates a stronger commitment from the CFO to achieve higher stock price performance for a portion of his equity compensation, which is a positive for shareholders as it raises the bar for the options to be in-the-money.

Negatives

• The issuance of new stock options (210,000 shares) represents potential future dilution for existing shareholders if and when exercised.

Future Outlook

The filing details the vesting schedules for the newly granted and repriced options, indicating future exercisability on specific annual anniversaries of the transaction dates.

Management Comments

• The Issuer's Board of Directors approved an option repricing whereby the Reporting Person's options were repriced to an exercise price of $4.50 per share.

Industry Context

NA

Corporate Governance

Stakeholder Impact

• Shareholders: Potential future dilution from the new option grant; improved alignment of the CFO's incentives with higher stock price targets due to the repricing of existing options to a higher exercise price.
• Employees (CFO): Increased potential for equity-based compensation if the company's stock price rises above the $4.50 exercise price for both new and repriced options.

Next Steps

• The second 1/3rd of the 210,000 options will become exercisable on or after the first annual anniversary of August 26, 2025.
• The third 1/3rd of the 210,000 options will become exercisable on or after the second annual anniversary of August 26, 2025.
• The repriced 71,429 options will continue to vest according to their original schedule, with portions becoming exercisable on annual anniversaries of their original award date.

Key Dates

Recommendation

This Form 4 details standard equity compensation events (new grant) and a less common, but positive for shareholders, repricing of existing options to a higher exercise price. While these actions align management incentives, they do not provide sufficient fundamental information to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and await further financial disclosures or strategic updates to assess the company's overall performance and outlook.

Keywords

Bimergen Energy Corp, BESS, Robert J Brilon, CFO, Director, Stock Options, Equity Compensation, Option Grant, Option Repricing, Insider Transaction, SEC Form 4